Filtros de búsqueda

Lista de obras de

Analysis of the serum bile Acid composition for differential diagnosis in patients with liver disease

artículo científico publicado en 2015

Anti-high mobility group box 1 monoclonal antibody improves ischemia/reperfusion injury and mode of liver regeneration after partial hepatectomy

artículo científico publicado en 2015

Chemotherapy for non-small cell lung cancer: split-dose administration of Cisplatin over four consecutive days and Vinorelbine ditartrate

artículo científico publicado en 2009

Estimating antihypertensive effects of combination therapy in an observational study using marginal structural models

artículo científico publicado en 2009

Impact of UGT1A1 genotype upon toxicities of combination with low-dose irinotecan plus platinum

artículo científico publicado en 2016

Mirogabalin for the management of postherpetic neuralgia: a randomized, double-blind, placebo-controlled phase 3 study in Asian patients

article

Oxidative stress markers, secondary bile acids and sulfated bile acids classify the clinical liver injury type: Promising diagnostic biomarkers for cholestasis

artículo científico publicado en 2015

Pharmacokinetics and Safety of a Single Oral Dose of Mirogabalin in Japanese Subjects With Varying Degrees of Renal Impairment

artículo científico publicado en 2017

Pravastatin use and cancer risk: a meta-analysis of individual patient data from long-term prospective controlled trials in Japan

artículo científico publicado en 2010

Survival analysis using inverse probability of treatment weighted methods based on the generalized propensity score

artículo científico publicado en 2010

The relationship between low-density lipoprotein cholesterol levels and the incidence of cardiovascular disease in high-risk patients treated with pravastatin: main results of the APPROACH-J study

artículo científico publicado en 2014

Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study

article published in 2019

Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive gastric cancer: a dose-expansion, phase 1 study

artículo científico publicado en 2019

Trastuzumab deruxtecan (DS-8201a) in subjects with HER2-expressing solid tumors: Long-term results of a large phase 1 study with multiple expansion cohorts

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda